Global Burden of cardiomyopathy and myocarditis in the older adults from 1990 to 2019

Dados Bibliográficos

ID22074396
AutoresKexin Zhang (0000-0002-7942-6850, Weifang Medical University), Xuebing Cheng (Weifang Medical University), Na Qu (0000-0003-2506-9779, Weifang Medical University), Hongwei Song (0009-0008-3183-0388, Weifang Medical University), Youhong Luo (Weifang Medical University), Tongtong Ye (Weifang Medical University), Qian Xu (0000-0001-8130-0846, Weifang Medical University), Hongzhan Tian (Weifang Medical University), Chengxia Kan (0000-0002-4593-0303, Weifang Medical University, autor correspondente), Ningning Hou (0000-0002-3813-8465, Weifang Medical University, autor correspondente)
Ano2022
Volume10
Páginas1018385-1018385
Data de publicação2022-09-23
Peer ReviewedSim
Open AccessSim
TipoARTICLE
PeriódicoFrontiers in Public Health (JOURNAL)
Identificadores do periódicoISSN: 2296-2565 • E-ISSN: 2296-2565
EditoraFrontiers Media SA (PUBLISHER • CH)
DOI10.3389/fpubh.2022.1018385
PMID36211688
OpenAlexW4296998303
IdiomaEN
Citações recebidas1
Referências citadas29

Background: Cardiomyopathy and myocarditis (CM-MC) are common chronic diseases causing heart failure in older adults. We aimed to analyze the burden of CM-MC in older adults aged 60-89 years at the global, regional, and national levels in 204 countries from 1990 to 2019. Methods: Detailed data on CM-MC from 1990 to 2019 were analyzed from the Global Burden of Diseases Study 2019, including incidence, mortality, disability-adjusted life years (DALYs) and the proportion of deaths caused by different risks factors. All results are presented as numbers, age-standardized rates per 100,000 person-years and estimated annual percentage change (EAPC) with an uncertainty interval of 95%. Results: Globally, there were 475,458 (339,942-638,363) incidence cases from CM-MC in 2019; with an age-standardized incidence rate (ASIR) of 16 (13-19.3) per 100,000 person-years. And there were 185,308 (154,610-200,448) deaths, with the age-standardized mortality rate (ASMR) being 4.4 (3.7-4.8). CM-MC resulted in 3,372,716 (2,931,247-3,693,622) DALYs, with an age-standardized DALYs rate (ASDR) of 114.8 (98.7-126.1). Estimated annual percentage change (EAPCs) for ARIS, ARMS, and ARDS has decreased. At the national level, the United States of America had the highest mortality [21,372 (18,924-24,241)] and disability-adjusted life years [407,712 (370,234-470,165)]. And China had the highest number of incident cases [122, 266 (85,925-166,095)]. Globally, high systolic blood pressure and alcohol consumption were the top two risk factors for the proportion of CM-MC deaths. Conclusion: CM-MC is still an important cause of early death and chronic disability in older adults. Based on this study, public health agencies should seek more effective methods to prevent and treat CM-MC

Cardiomyopathy · Environmental health · Heart failure · Life expectancy · Mortality rate · Population · Years of potential life lost · Cardiomyopathy and Myosin Studies · Demography · Eosinophilic Disorders and Syndromes · Medicine · Viral Infections and Immunology Research · Internal Medicine · Pediatrics